Mekophar Chemical Pharmaceutical Joint-Stock Company
Mekophar Chemical Pharmaceutical Joint-Stock Company
🇻🇳 Vietnam, Ho Chi Minh City (HCMC)
1975501-1000 peopleManufacturer/Trading Company/DistributorMekophar Chemical Pharmaceutical Joint-Stock Company (MEKOPHAR) is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. Established in 1975 and equitized as a joint-stock company in 2002, the organization has grown into a major industry player with a workforce of approximately 500 to 1,000 employees and an annual revenue estimated at $157.9 million. The company operates multiple production bases and a nationwide distribution network with branches in Hanoi, Da Nang, and Can Tho.
Mekophar specializes in a comprehensive range of healthcare solutions, including the manufacturing, export, and import of pharmaceuticals, herbal medicines, and oriental medicines. Its extensive product portfolio covers therapeutic areas such as antibiotics (oral and injectable), analgesics, antipyretics, cardiovascular drugs, gastrointestinal agents, and antimalarials. Beyond finished dosage forms, the company supplies pharmaceutical raw materials, medical devices, and specialized packaging solutions including plastic bottles and carton boxes.
As a vertically integrated manufacturer, Mekophar offers OEM services and maintains a focus on high-quality standards to serve both domestic and international markets. The company has also diversified its business interests into stem cell banking services through its relationship with Mekostem, as well as food technology and cosmetics. Listed on the UPCOM securities trading center under the ticker MKP, Mekophar remains a key contributor to the regional pharmaceutical sector through its commitment to safe and effective public health products.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High capacity factoryCan handle large-scale or bulk production orders.
Industry association memberMember of Vietnam Pharmaceutical Corporation association.
Contact
*****************
5
*****************
1
Products
Mekophar company building
Mekophar Logo
Mekophar Building
pharmaceuticals
Customers
NIPRO
***
*************************
************
**********
Unlock all 11 customers
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Pymepharco Joint Stock Company
🇻🇳 Vietnam
19891001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
668
Key customer
MERIEUX NUTRISCIENCES
Key market
🇻🇳 Vietnam
Description
Pymepharco Joint Stock Company is a leading pharmaceutical manufacturer and distributor based in Tuy Hoa, Vietnam. Established as a subsidiary of the global STADA Group, the company has evolved from a local medical supplier into a major regional player with a workforce of over 1,000 employees. Pymepharco specializes in the production of high-quality generic pharmaceuticals, prescription drugs, and OTC medicines, with a particular focus on antibiotics such as Cephalosporin. Their extensive product portfolio includes analgesics, antipyretics, anti-inflammatory drugs, vitamins, minerals, and dietary supplements, as well as medical equipment and medicinal chemicals.
The company operates advanced manufacturing facilities, including the modern PME II factory, which features a production capacity of 1.2 billion tablets per shift annually. Pymepharco is distinguished as a pioneer in Vietnam for achieving EU-GMP standards, ensuring their injectable powders, tablets, soft and hard capsules, and granules meet international quality benchmarks. In addition to its own branded products, the company provides OEM services and maintains strategic partnerships with international firms like Enzymatica. As a key contributor to the Southeast Asian pharmaceutical supply chain, Pymepharco focuses on delivering affordable, high-quality healthcare solutions through sustainable development and advanced scientific applications.
Pymepharco Building
Imexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19771001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
27
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide.
Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions.
As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Tiểu đường
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Mắt
